The medicinal product does not meet quality requirements due to a negative test result for the particle size analysis parameter in the prolonged-release suspension for injection. Potential effects: abnormal dose release, reduced efficacy or increased risk of adverse reactions.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch 4201475, check the batch number on the packaging and return any packs held to a pharmacy; if the product has been used, consult a doctor.
Withdrawal of batch 4201475 of Egoropal from the market throughout the country and a ban on placing this batch on the market, with the decision given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related